Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Completed Secondary Placing

9 Apr 2014 13:52

RNS Number : 4068E
Quixant PLC
09 April 2014
 



9 April 2014

Quixant Plc

("Quixant" or the "Company")

 

£25m placing of 17,857,143 existing Ordinary Shares

 

Quixant (AIM:QXT) a leading provider of specialised computing platforms for casino gaming machine applications, is pleased to announce that in order to satisfy market demand and broaden the institutional shareholder base of the Company, finnCap, as the Company's broker, have conducted an oversubscribed placing of 17,857,143 existing ordinary shares of 0.01p in the Company (the "Placing Shares" and the "Placing") with new and existing institutional investors.

 

The Placing Shares have been sold on behalf of certain directors of the Company and their connected persons (the "Director Vendors") and certain other founder shareholders of the Company (the "Vendor Shareholders"). The Placing Shares were sold at a price of 140 pence per share and represent, in aggregate, 27.6 per cent. of the issued share capital of Quixant.

 

The Director Vendors have been released by finnCap from the terms of their respective lock-in obligations, as set out in paragraph 15 of Part II of the Company's Admission Document dated 21 May 2013 (the "Admission Document") to the extent of the Placing Shares sold in the Placing. All ordinary shares held by the Director Vendors subsequent to the Placing will remain subject to the lock-in obligations and orderly market arrangements set out in the Admission Document. All ordinary shares held by the Vendor Shareholders subsequent to the Placing remain subject to the orderly marketing arrangements set out in paragraph 15 of Part II of the Admission Document.

 

Subsequent to the Placing, the Director Vendors revised shareholdings are set out below.

 

Director

Placing Shares sold

Resultant shareholding

 

Number of Ordinary Shares

% of issued share capital

Number of Ordinary Shares

% of Enlarged Share Capital

Nick Jarmany

8,109,347

12.5%

16,752,923(1)

25.9%

Gary Mullins

3,142,173

4.9%

4,058,641(2)

6.3%

Chen Tai Lin

2,221,739

3.4%

4,589,842(3)

7.1%

 

(1) Mr Jarmany's holding includes 5,573,379 Ordinary Shares, representing 8.6 per cent. of the issued share capital of the Company, registered in the name of his wife, Francesca Marzilli.

 

(2) Mr Mullins' holding includes 389,233 Ordinary Shares, representing 0.6 per cent. of the issued share capital of the Company, registered in the name of his wife, Sophie Jayne Mullins

 

(3) Mr Lin's holding includes 1,167,700 Ordinary Shares, representing 1.8 per cent. of the issued share capital of the Company, registered in the name of his wife, Shu-Hsiang Wu.

 

Subsequent to the Placing the Founder Shareholders revised shareholdings are set out below.

 

Vendor Shareholder

Placing Shares sold

Resultant shareholding

 

Number of Ordinary Shares

% of issued share capital

Number of Ordinary Shares

% of Enlarged Share Capital

Alex Taylor

1,269,565

2.0%

2,662,767

4.1%

Mark Mullins

2,380,434

3.7%

2,484,981

3.8%

Daniel Jarmany

407,714

0.6%

842,286

1.3%

Tim Moulson

326,171

0.5%

673,829

1.0%

 

Nick Jarmany, CEO of Quixant, commented: "Since our IPO in May last year it became increasingly clear to us that greater liquidity was necessary for the long term benefit of the Company. By successfully completing this Placing we have satisfied significant institutional demand and broadened our shareholder base. I am very pleased with the calibre and support of existing and new shareholders and look forward to continuing to implement our growth strategy."

 

Enquiries

 

Quixant plc

Nick Jarmany (Chief Executive)
Jon Jayal (General Manager)

+44(0)1223 892 696

 

Nominated Adviser and Broker:

finnCap Limited

Matt Goode (Corporate Finance)

Charlotte Stranner (Corporate Finance)

Victoria Bates (Corporate Broking)

 

 

+44(0)20 7220 0500

Financial PR:

Newgate Threadneedle

John Coles / Fiona Conroy / Hilary Millar

 

+44(0)20 7653 9850

 

 

About Quixant

Quixant, founded in 2005, designs and manufactures complete advanced hardware and software solutions (Gaming Platforms) for the pay-for-play gaming and slot machine industry. The Company is headquartered outside of Cambridge in the UK. Quixant UK Ltd is responsible for the group's global (excluding North America) sales function and its Las Vegas based subsidiary, Quixant USA Inc, is responsible for sales and sales support to the North American market. Quixant has its own manufacturing and engineering operation in Taiwan, which has evolved with the rapid growth of the Company. Quixant's Italian subsidiary, Quixant Italia, houses the Group's software engineering and customer support team.

 

Quixant's high quality, specialised products provide an all-in-one solution, based on PC technology but with augmentative hardware features and operating software developed specifically to address the requirements of the gaming industry. Products feature innovative mechanical designs which are optimised for operation in the gaming and slot machine environment. Quixant's proprietary hardware and embedded software is flexible in its design, enabling Quixant to easily respond to changes in regulation or customers operating in different markets or jurisdictions.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUGUAWCUPCUQB
Date   Source Headline
15th Mar 20177:00 amRNSSenior Management Update
2nd Mar 20177:00 amRNSNotice of Results
27th Jan 20177:00 amRNSTrading Update and Notice of Results
22nd Dec 201611:16 amRNSHolding(s) in Company
20th Dec 20165:06 pmRNSResult of Placing
20th Dec 20163:04 pmRNSProposed Secondary Placing
24th Nov 20162:05 pmRNSSecond Price Monitoring Extn
24th Nov 20162:00 pmRNSPrice Monitoring Extension
24th Nov 201611:05 amRNSSecond Price Monitoring Extn
24th Nov 201611:00 amRNSPrice Monitoring Extension
24th Nov 20167:00 amRNSTrading Update
21st Nov 20163:26 pmRNSAppointment of Company Secretary
27th Oct 20166:27 pmRNSHolding(s) in Company
19th Oct 20164:54 pmRNSIssue of Equity
6th Oct 20161:38 pmRNSIssue of Equity
21st Sep 20165:03 pmRNSHolding(s) in Company
14th Sep 20167:00 amRNSHalf-year Report
11th Aug 20167:00 amRNSNotice of Interim Results
27th Jul 20167:00 amRNSTrading Update and Notice of Results
20th Jun 20167:00 amRNSBoard Appointment
15th Jun 20164:57 pmRNSDirector Dealing
9th Jun 20164:32 pmRNSIssue of Equity
7th Jun 20167:00 amRNSHolding(s) in Company
23rd May 20168:17 amRNSSigning of Multi-Year Contract
26th Apr 201611:46 amRNSResult of AGM
6th Apr 20166:18 pmRNSDirector Dealing
6th Apr 20167:00 amRNSHolding(s) in Company
4th Apr 201610:53 amRNSCompleted Secondary Placing
23rd Mar 20167:00 amRNSFinal Results
19th Feb 20167:00 amRNSNotice of Results
15th Feb 201611:29 amRNSHolding(s) in Company
21st Jan 20167:00 amRNSTrading Update
13th Nov 20159:32 amRNSHolding(s) in Company
11th Nov 20157:00 amRNSCompletion of Acquisition
10th Nov 20153:40 pmRNSScheme of Arrangement Becomes Effective
6th Nov 201511:33 amRNSScheme of Arrangement Sanctioned By Court
3rd Nov 20155:13 pmRNSResults of Court Meeting and General Meeting
9th Oct 20157:00 amRNSPosting of Scheme Document
2nd Oct 201510:33 amRNSHolding in Company
1st Oct 20153:36 pmRNSForm 8 (OPD) Densitron Technologies plc
30th Sep 20153:33 pmRNSForm 8 (OPD) Quixant plc
25th Sep 20157:00 amRNSRule 2.7 Announcement
16th Sep 20157:00 amRNSHalf Yearly Report
3rd Aug 20159:48 amRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Update and Notice of Results
21st Apr 20157:00 amRNSQueen's Award for Enterprise
16th Apr 201511:01 amRNSResult of AGM
24th Mar 20151:41 pmRNSPosting of Annual Report and Accounts
24th Mar 20157:00 amRNSFinal Results
4th Mar 20157:00 amRNSNotice of Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.